These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


136 related items for PubMed ID: 21542297

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Genetic polymorphisms in MDR1 and CYP3A5 and MDR1 haplotype in mainland Chinese Han, Uygur and Kazakh ethnic groups.
    Li D, Zhang GL, Lou YQ, Li Q, Wang X, Bu XY.
    J Clin Pharm Ther; 2007 Feb; 32(1):89-95. PubMed ID: 17286792
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Frequency of CYP2D6*10 and *14 alleles and their influence on the metabolic activity of CYP2D6 in a healthy Chinese population.
    Cai WM, Chen B, Zhang WX.
    Clin Pharmacol Ther; 2007 Jan; 81(1):95-8. PubMed ID: 17186005
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Allele and genotype frequencies of CYP3A4, CYP2C19, and CYP2D6 in Han, Uighur, Hui, and Mongolian Chinese populations.
    Zuo LJ, Guo T, Xia DY, Jia LH.
    Genet Test Mol Biomarkers; 2012 Feb; 16(2):102-8. PubMed ID: 22224559
    [Abstract] [Full Text] [Related]

  • 7. Genetic and epigenetic polymorphisms of eNOS and CYP2D6 in mainland Chinese Tibetan, Mongolian, Uygur, and Han populations.
    Qi G, Yin S, Zhang G, Wang X.
    Pharmacogenomics J; 2020 Feb; 20(1):114-125. PubMed ID: 31616043
    [Abstract] [Full Text] [Related]

  • 8. Ethnic disparities in the clustering of risk factors for cardiovascular disease among the Kazakh, Uygur, Mongolian and Han populations of Xinjiang: a cross-sectional study.
    Li N, Wang H, Yan Z, Yao X, Hong J, Zhou L.
    BMC Public Health; 2012 Jul 03; 12():499. PubMed ID: 22759741
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Distribution of CYP2D6 and CYP2C19 gene polymorphisms in Han and Uygur populations with breast cancer in Xinjiang, China.
    Abudukeremu M, Ayoufu A, Tuerhong A, Paizula X, Ou JH.
    Open Life Sci; 2024 Jul 03; 19(1):20220728. PubMed ID: 38681733
    [Abstract] [Full Text] [Related]

  • 11. Relationship between EPHX2 gene polymorphisms and essential hypertension in Uygur, Kazakh, and Han.
    Zhu XL, Wang L, Wang Z, Chen SZ, Zhang WQ, Ma MM.
    Genet Mol Res; 2015 Apr 15; 14(2):3474-80. PubMed ID: 25966114
    [Abstract] [Full Text] [Related]

  • 12. A common missense single nucleotide polymorphism in the E-selectin gene is significantly associated with essential hypertension in the Han population but only weakly associated in the Uygur population.
    Wang Z, Xu Y, Chen S, Wang L, Ding H, Lu G, Wang D, Zhai Z, Duan J, Zhang W.
    Hypertens Res; 2012 Apr 15; 35(4):413-7. PubMed ID: 22158116
    [Abstract] [Full Text] [Related]

  • 13. Effects of the Chinese herbal formula "Zuojin Pill" on the pharmacokinetics of dextromethorphan in healthy Chinese volunteers with CYP2D6*10 genotype.
    Qiu F, Liu S, Miao P, Zeng J, Zhu L, Zhao T, Ye Y, Jiang J.
    Eur J Clin Pharmacol; 2016 Jun 15; 72(6):689-95. PubMed ID: 27023460
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Functional allele and genotype frequencies of CYP1A2, CYP2B6 and iNOS among mainland Chinese Tibetan, Mongolian, Uygur and Han populations.
    Qi GZ, Zhang ZY, Wang X, Yin SJ, Lou YQ, Zhang GL.
    J Clin Pharm Ther; 2016 Feb 15; 41(1):84-91. PubMed ID: 26763760
    [Abstract] [Full Text] [Related]

  • 16. Frequencies of CYP2D6 mutant alleles in a normal Japanese population and metabolic activity of dextromethorphan O-demethylation in different CYP2D6 genotypes.
    Kubota T, Yamaura Y, Ohkawa N, Hara H, Chiba K.
    Br J Clin Pharmacol; 2000 Jul 15; 50(1):31-4. PubMed ID: 10886115
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Genetic polymorphisms of drug-metabolizing phase I enzymes CYP3A4, CYP2C9, CYP2C19 and CYP2D6 in Han, Uighur, Hui and Mongolian Chinese populations.
    Zuo J, Xia D, Jia L, Guo T.
    Pharmazie; 2012 Jul 15; 67(7):639-44. PubMed ID: 22888523
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.